Spravato

For Adults with Treatment-Resistant Depression

Spravato Contact Form

Looking to be a new patient for Spravato Treatment?
Fill out the form below and a team member will get back to you as soon as possible.

Patient's Legal Name
Patient's Full Address Including City, State, and Zip Code
Patient's Date of Birth
Patient's Legal Gender
Patient's Gender Identity
Best Number to Reach You (We only make contact by phone and will leave a voicemail)
Email
PCP's Name and Phone Number
Therapist's Name
Insurance Carrier
Insurance Policy Number
How did you hear about Spravato at PTX?
Prefer Appointments In? Write in Framingham or Acton
I understand that I will have an initial evaluation with a clinician before being admitted to the Spravato program and given Spravato treatment. Write in Yes or No

Accepted Insurance

Below are the insurances we accept for Spravato Treatment. We do not bill out of network insurance companies. If you have any questions or concerns, please reach out to your insurance carrier directly about coverage.

Blue Cross Blue Shield

Commercial Plans:

BCBS Advantage
Blue Benefit Administrator (CBA)
Medicare Advantage Plans

BCBS Federal

Optum

Commercial Plans:
Mass General Brigham
United Healthcare
UHC Student Resources
Health Plans Inc.
UMR

Point 32 Health

Commercial Plans:
Harvard Pilgrim Healthcare
Tufts Medicare Advantage
Tufts Commercial

Medicare

National Government Services

Spravato

(Esketemine) Nasal Treatment

SPRAVATO® is a prescription nasal spray used to treat adults with treatment resistant depression. SPRAVATO® is the first nasal spray approved by the FDA for specifically treating adults with treatment resistant depression. SPRAVATO® is a fast-acting treatment, with clients often feeling relief within hours.

Learn More